CDCA7L antibody (Middle Region)
Quick Overview for CDCA7L antibody (Middle Region) (ABIN632453)
Target
See all CDCA7L AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- CDCA7 L antibody was raised against the middle region of CDCA7
-
Purification
- Affinity purified
-
Immunogen
- CDCA7 L antibody was raised using the middle region of CDCA7 corresponding to a region with amino acids PPCRGICNCSYCRKRDGRCATGILIHLAKFYGYDNVKEYLESLQKELVED
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CDCA7L Blocking Peptide, (ABIN5612779), is also available for use as a blocking control in assays to test for specificity of this CDCA7L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CDCA0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CDCA7L (Cell Division Cycle Associated 7-Like (CDCA7L))
-
Alternative Name
- CDCA7L
-
Background
- CDCA7L plays an important oncogenic role in mediating the full transforming effect of MYC in medulloblastoma cells. CDCA7L is involved in apoptotic signaling pathways. CDCA7L may act downstream of P38-kinase and BCL-2, but upstream of CASP3/caspase-3 as well as CCND1/cyclin D1 and E2F1.
-
Molecular Weight
- 46 kDa (MW of target protein)
Target
-